Protein Detection And Quantification Global Market Report 2024

Protein detection and quantification involves identifying and measuring proteins in biological samples using diverse techniques and assays. These processes are crucial in research, diagnostics, and industry, supporting endeavors such as biomarker discovery, drug development, clinical diagnostics, proteomics, biomanufacturing quality control, and personalized medicine.

Key products in protein detection and quantification include kits and reagents, instruments, and services. Kits and reagents are vital for protein detection assays, containing specialized substances that interact with proteins to facilitate their detection and quantification. These kits typically consist of antibodies, enzymes, substrates, and buffers tailored for specific protein assays. Various technologies employed include colorimetric assays, immunological methods, chromatography, mass spectrometry, spectroscopy instruments, and others. These technologies find applications in drug discovery, clinical diagnostics, and more, serving end users such as academic research institutes, biotechnology firms, pharmaceutical companies, contract research organizations, and others.

The protein detection and quantification market research report is one of a series of new reports that provides protein detection and quantification market statistics, including protein detection and quantification industry global market size, regional shares, competitors with a protein detection and quantification market share, detailed protein detection and quantification market segments, market trends and opportunities, and any further data you may need to thrive in the protein detection and quantification industry. This protein detection and quantification market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The protein detection and quantification market size grown rapidly in recent years. It will grow from $2.09 billion in 2023 to $2.28 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. Historic period growth can be linked to the rising incidence of chronic diseases, expanded use in clinical diagnostics, a growing focus on personalized medicine, and increasing demand for proteomics research.

The protein detection and quantification market size is expected to see rapid growth in the next few years. It will grow to $3.22 billion in 2028 at a compound annual growth rate (CAGR) of 9%. Forecasted growth is expected due to heightened demand for personalized medicine, expanding applications in biotechnology and clinical diagnostics, increased adoption of automation and robotics, and the rise of point-of-care testing. Key trends in the forecast period include the integration of AI-powered platforms, collaborations and partnerships, technological advancements, and advancements in multiplexing research.

The increasing demand for personalized medicine is expected to drive growth in the protein detection and quantification market. Personalized medicine involves tailoring medical treatments to individual patient needs, leveraging advancements in omics technology, data integration, genetics, and the importance of customized patient-specific therapies and preventive measures. Protein detection and quantification play a crucial role in personalized medicine by identifying and measuring specific proteins that serve as biomarkers for tailored patient care. For instance, in 2022, the Personalized Medicine Coalition reported that 12 new personalized medicines were approved, accounting for approximately 34% of all newly approved treatments, marking a significant increase compared to previous years. Thus, the rising demand for personalized medicine is a key driver of growth in the protein detection and quantification market.

Leading companies in the protein detection and quantification market are focusing on innovation, such as the development of protein co-detection kits, to maintain their market position. These kits enable simultaneous detection of multiple proteins within a sample, utilizing specific antibodies or probes for different target proteins, accompanied by necessary reagents and detection protocols. For example, Vizgen Inc., a US-based biotechnology firm, launched the Protein Co-detection Kit for the MERSCOPE Platform in September 2022. This kit enhances capabilities in capturing spatial gene expression and protein localization, facilitating comprehensive single-cell analysis and deeper insights into complex biological processes. It provides researchers with a robust toolset for studying cellular diversity, biomarker identification, and disease mechanisms, thereby advancing precision medicine and therapeutic development.

In February 2022, WATERS Corporation, a US-based provider of analytical instruments and software, acquired technology assets from Megadalton Solutions Inc. for an undisclosed sum. This acquisition aimed to expand Waters' applications in cell and gene therapy, leveraging Megadalton Solutions' innovative CDMS technology. Megadalton Solutions Inc. is a US-based early-stage charge detection mass spectrometry (CDMS) technology and services developer.

Major companies operating in the protein detection and quantification market are Roche Diagnostics, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare, Agilent Technologies Inc., Illumina Inc., Sartorius AG, PerkinElmer Inc., Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Horiba ltd., Bio-Techne Corporation, Promega Corporation, Abcam Plc, Molecular Devices LLC, Olink Proteomics, RayBiotech Life Inc., Bio Scientific Research Laboratories.

North America was the largest region in the protein detection and quantification market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein detection and quantification market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the protein detection and quantification market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The protein detection and quantification market consists revenues earned by entities by providing services such as protein profiling, protein quantification, clinical testing services, and assay development. The market value includes the value of related goods sold by the service provider or included within the service offering. The protein detection and quantification market also includes sales of western blotting reagents and kits, protein quantification assays, mass spectrometry consumables, protein purification kits, and automated protein analysis systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.